References
- Heusch G. Molecular basis of cardio protection: signal transduction is ischemic pre-, post-, and remote conditioning. Circ Res. 2015;116:674–99.
- Kloner RA. Current state of clinical translation of cardioprotective agents for acute myocardial infarction. Circ Res. 2013;113:451–63.
- Heusch G, Bøther HE, Pryzklenk K, Redington A, Yellon D. Remote ischemic conditioning. J Am Coll Cardiol. 2015;65: 177–96.
- Krogstad LEB, Slagsvold KH, Wahba A. Remote ischemic preconditioning and incidence of postoperative atrial fibrillation. Scand Cardiovasc J. 2015;49:this issue.
- Slagsvold KH, Rognmo Ø, Høydal M, Wisløff U, Wahba A. Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circ Res. 2014;114:851–9.
- Przyklenk K, Sanderson TH, Hϋttemann M. Clinical benefits of remote ischemic preconditioning. New insights….and new questions. Circ Res. 2014;114:748–50.
- Jones SP, Tang XL, Guo Y, Steenbergen C, Lefer DJ, Kukreja RC, et al. The NHLBI-sponsored consortium for preclinical assessment of cardiotherapy (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs. Circ Res. 2015;116:572–86.
- Hausenloy DJ, Bøtker HJ, Condorelli G, Ferdinandy P, Garcia-Dorado D, Heusch G, et al. Translating cardioprotection for patient benefit; position paper from the working group of cellular biology of the heart of the European Cardiology Society. Cardiovasc Res. 2013;98:7–27.